Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck and Company    MRK

MERCK AND COMPANY

(MRK)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about MERCK AND COMPANY
11/21MERCK AND : European Commission Approves Two New Regimens of Merck's KEYTRUDA as..
AQ
11/20MERCK AND : Gets EC Approval For Keytruda Regimens in Head, Neck Cancer
DJ
11/20MERCK AND : European Commission Approves Two New Regimens of Merck's KEYTRUDA® (..
BU
11/19MERCK AND : & Co. Raises Quarterly Dividend by 10.9% to 61 Cents
DJ
11/19MERCK : Announces First-Quarter 2020 Dividend
BU
11/18MERCK AND : Ontario and Quebec provide reimbursement for HIV therapies PIFELTRO®..
AQ
11/18MERCK AND : Bayer Drug Vericiguat Meets Primary Endpoint in Phase 3 Study
DJ
11/18MERCK : and Bayer's Investigational Drug Vericiguat Meets Primary Endpoint in Ph..
BU
11/18MERCK AND : - BRAVECTO PLUS for Cats Receives Approval from US Food and Drug Adm..
AQ
11/15MERCK AND : AstraZeneca - US FDA accepts regulatory submission for selumetinib i..
AQ
11/15MERCK AND : Gets FDA OK for Bravecto Plus Topical Solution for Cats
DJ
11/15MERCK AND : BRAVECTO® PLUS (fluralaner and moxidectin topical solution) for Cats..
BU
11/14MERCK AND : ERVEBO® Awarded Prequalification Status by the World Health Organiza..
AQ
11/14Merck, AstraZeneca Get FDA Priority Review for Selumetinib in NF1
DJ
11/14MERCK AND : US FDA Accepts Regulatory Submission of New Drug Application for Sel..
BU
More most relevant news
All news about MERCK AND COMPANY
11/21MERCK AND : European Commission Approves Two New Regimens of Merck's KEYTRUDA as..
AQ
11/20UPS to Use Sensors That Can Track Medical Packages at All Times
DJ
11/20MERCK AND : Gets EC Approval For Keytruda Regimens in Head, Neck Cancer
DJ
11/20MERCK AND : European Commission Approves Two New Regimens of Merck's KEYTRUDA® (..
BU
11/19MERCK AND : & Co. Raises Quarterly Dividend by 10.9% to 61 Cents
DJ
11/19MERCK : Announces First-Quarter 2020 Dividend
BU
11/19FDA Accepts Avastin Biosimilar BLA From Biogen, Samsung BioLogics Venture
DJ
11/18MERCK AND : Ontario and Quebec provide reimbursement for HIV therapies PIFELTRO®..
AQ
11/18MERCK AND : Bayer Drug Vericiguat Meets Primary Endpoint in Phase 3 Study
DJ
11/18MERCK : and Bayer's Investigational Drug Vericiguat Meets Primary Endpoint in Ph..
BU
More news
News in other languages on MERCK AND COMPANY
11/21WDH/VERGLEICH DEUTSCHER STÄDTE : Darmstadt ist Zukunft, Berlin Dynamik
11/21STÄDTERANKING : Neue und alte Spitzenreiter
11/20MERCK : Keytruda obtient une approbation de l'UE
11/19DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 19.11.2019 - 15.15 Uhr
11/19KREISE : Merck KGaA erwägt Verkauf des Pigment-Geschäfts
11/18BAYER : résultats positifs pour une étude sur Vericiguat
11/18Bayer macht beim Herzmedikament Vericiguat Fortschritte
11/14DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 14.11.2019 - 15.15 Uhr
11/14Aktien Frankfurt: Atempause nach imposanter Rally
11/14STEFAN OSCHMANN : Merck setzt sich nach Versum-Übernahme höhere Ziele - Aktie si..
Press releases
11/21MERCK AND : European Commission Approves Two New Regimens of Merck's KEYTRUDA as..
AQ
11/20MERCK AND : European Commission Approves Two New Regimens of Merck's KEYTRUDA® (..
BU
11/19MERCK : Announces First-Quarter 2020 Dividend
BU
11/18MERCK AND : Ontario and Quebec provide reimbursement for HIV therapies PIFELTRO®..
AQ
11/18MERCK : and Bayer's Investigational Drug Vericiguat Meets Primary Endpoint in Ph..
BU
More press releases
Sector news : Pharmaceuticals - NEC
01:14pSANOFI : Head of Strategy to Retire -- Reuters
DJ
10:37aAstraZeneca shares rise on early U.S. approval for leukaemia drug
RE
10:35aDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
09:49aALLERGAN : Form 8.3 -
DJ
09:44aABBVIE : Form 8.3 -
DJ
More sector news : Pharmaceuticals - NEC
Upcoming event on MERCK AND COMPANY